Suchergebnisse - "Brai, Annalaura"

PubPharm (7)

1

Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors

enthalten in: European journal of medicinal chemistry | 2024

von Di Stefano, M. | Masoni, S. | Bononi, G. | +19

2

Reversible Monoacylglycerol Lipase Inhibitors : Discovery of a New Class of Benzylpiperidine Derivatives

enthalten in: Journal of medicinal chemistry | 2022

von Bononi, G. | Di Stefano, M. | Poli, G. | +17

3

Unique Domain for a Unique Target : Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses

enthalten in: Journal of medicinal chemistry | 2020

von Riva, V. | Garbelli, A. | Brai, A. | +12

4

DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins

enthalten in: European journal of medicinal chemistry | 2020

von Brai, A. | Riva, V. | Saladini, F. | +13

5

DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses : The coxsackie B model

enthalten in: Antiviral research | 2020

von Quaranta, P. | Lottini, G. | Chesi, G. | +9

6

DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection

enthalten in: Journal of medicinal chemistry | 2019

von Brai, A. | Martelli, F. | Riva, V. | +10

7

Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2016

von Brai, A. | Fazi, R. | Tintori, C. | +15

1
[1]